Ignite Creation Date:
2025-12-26 @ 10:57 AM
Ignite Modification Date:
2025-12-31 @ 3:23 PM
Study NCT ID:
NCT01512108
Status:
COMPLETED
Last Update Posted:
2017-12-18
First Post:
2012-01-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD Alone
Sponsor:
Novo Nordisk A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-01-10
Start Date Type:
ACTUAL
Primary Completion Date:
2013-04-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-04-26
Completion Date Type:
ACTUAL
First Submit Date:
2012-01-10
First Submit QC Date:
None
Study First Post Date:
2012-01-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-04-25
Results First Submit QC Date:
None
Results First Post Date:
2014-05-28
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-11-08
Last Update Post Date:
2017-12-18
Last Update Post Date Type:
ACTUAL